menu Search
Cerebrolysin

Cerebrolysin Adverse Reactions

Manufacturer:

Ever Neuro Pharma

Distributor:

Getz Bros
NEW Brand Resources
Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Adverse Reactions Caution For Usage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources
Full Prescribing Info
Adverse Reactions
Safety: The experience with Cerebrolysin during many years of clinical application, the information from post-marketing surveillance studies, the safety data from double-blind, placebo-controlled clinical trials and EVER's pharmacovigilance database demonstrate the excellent clinical safety profile of Cerebrolysin.
According to EMA classification (European Medicines Agency), Cerebrolysin is in the SAFE category.
In general, reported adverse drug reactions are transient and mild in intensity.
Cerebrolysin is safe and well tolerated.
View ADR Reporting Link